Enhanced ROS Production in Oncogenically Transformed Cells Potentiates c-Jun N-Terminal Kinase and p38 Mitogen-Activated Protein Kinase Activation and Sensitization to Genotoxic Stress

REFERENCES

• Adler, V., Z. Yin, K. D. Tew, and Z. Ronai. 1999. Role of redox potential and reactive oxygen species in stress signaling. Oncogene 18:6104–6111.
   PubMed Web of Science ®Google Scholar
• Alessi, D. R., A. Cuenda, P. Cohen, D. T. Dudley, and A. R. Saltiel. 1995. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270:27489–27494.
   PubMed Web of Science ®Google Scholar
• Arteaga, C. L., A. R. Winnier, M. C. Poirier, D. M. Lopez-Larraza, L. K. Shawver, S. D. Hurd, and S. J. Stewart. 1994. p185c-erbB-2 signal enhances cisplatin-induced cytotoxicity in human breast carcinoma cells: association between an oncogenic receptor tyrosine kinase and drug-induced DNA repair. Cancer Res. 54:3758–3765.
   PubMed Web of Science ®Google Scholar
• Basu, A., and J. S. Cline. 1995. Oncogenic transformation alters cisplatin-induced apoptosis in rat embryo fibroblasts. Int J. Cancer 63:597–603.
   PubMed Web of Science ®Google Scholar
• Boussif, O., F. Lezoualc'h, M. A. Zanta, M. D. Mergny, D. Scherman, B. Demeneix, and J. P. Behr. 1995. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. USA 92:7297–7301.
   PubMed Web of Science ®Google Scholar
• Brenner, B., U. Koppenhoefer, C. Weinstock, O. Linderkamp, F. Lang, and E. Gulbins. 1997. Fas- or ceramide-induced apoptosis is mediated by a Rac1-regulated activation of Jun N-terminal kinase/p38 kinases and GADD153. J. Biol. Chem. 272:22173–22181.
   PubMed Web of Science ®Google Scholar
• Butterfield, L., B. Storey, L. Maas, and L. E. Heasley. 1997. c-Jun NH2-terminal kinase regulation of the apoptotic response of small cell lung cancer cells to ultraviolet radiation. J. Biol. Chem. 272:10110–10116.
   PubMed Web of Science ®Google Scholar
• Carpenter, G., and S. Cohen. 1976. 125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts. J. Cell Biol. 71:159–171.
   PubMed Web of Science ®Google Scholar
• Chan, W. H., and J. S. Yu. 2000. Inhibition of UV irradiation-induced oxidative stress and apoptotic biochemical changes in human epidermal carcinoma A431 cells by genistein. J. Cell. Biochem. 78:73–84.
   PubMed Web of Science ®Google Scholar
• Chen, C. Y., F. Del Gatto-Konczak, Z. Wu, and M. Karin. 1998. Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway. Science 280:1945–1949.
   PubMed Web of Science ®Google Scholar
• Chen, G., J. Shu, and D. W. Stacey. 1997. Oncogenic transformation potentiates apoptosis, S-phase arrest and stress-kinase activation by etoposide. Oncogene 15:1643–1651.
   PubMedGoogle Scholar
• Chen, W., J. L. Martindale, N. J. Holbrook, and Y. Liu. 1998. Tumor promoter arsenite activates extracellular signal-regulated kinase through a signaling pathway mediated by epidermal growth factor receptor and Shc. Mol. Cell. Biol. 18:5178–5188.
   PubMed Web of Science ®Google Scholar
• Chen, Y. R., X. Wang, D. Templeton, R. J. Davis, and T. H. Tan. 1996. The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation. J. Biol. Chem. 271:31929–31936.
   PubMed Web of Science ®Google Scholar
• Chen, Z., H. Seimiya, M. Naito, T. Mashima, A. Kizaki, S. Dan, M. Imaizumi, H. Ichijo, K. Miyazono, and T. Tsuruo. 1999. ASK1 mediates apoptotic cell death induced by genotoxic stress. Oncogene 18:173–180.
   PubMedGoogle Scholar
• Cuenda, A., J. Rouse, Y. N. Doza, R. Meier, P. Cohen, T. F. Gallagher, P. R. Young, and J. C. Lee. 1995. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364:229–233.
   PubMed Web of Science ®Google Scholar
• Cui, X. L., and J. G. Douglas. 1997. Arachidonic acid activates c-jun N-terminal kinase through NADPH oxidase in rabbit proximal tubular epithelial cells. Proc. Natl. Acad. Sci. USA 94:3771–3776.
   PubMed Web of Science ®Google Scholar
• DeClue, J. E., W. C. Vass, A. G. Papageorge, D. R. Lowy, and B. M. Willumsen. 1991. Inhibition of cell growth by lovastatin is independent of ras function. Cancer Res. 51:712–717.
   PubMed Web of Science ®Google Scholar
• de Stanchina, E., M. E. McCurrach, F. Zindy, S. Y. Shieh, G. Ferbeyre, A. V. Samuelson, C. Prives, M. F. Roussel, C. J. Sherr, and S. W. Lowe. 1998. E1A signaling to p53 involves the p19(ARF) tumor suppressor. Genes Dev. 12:2434–2442.
   PubMed Web of Science ®Google Scholar
• Dixit, M., J. L. Yang, M. C. Poirier, J. O. Price, P. A. Andrews, and C. L. Arteaga. 1997. Abrogation of cisplatin-induced programmed cell death in human breast cancer cells by epidermal growth factor antisense RNA. J. Natl. Cancer Inst. 89:365–373.
   PubMed Web of Science ®Google Scholar
• Dorward, A., S. Sweet, R. Moorehead, and G. Singh. 1997. Mitochondrial contributions to cancer cell physiology: redox balance, cell cycle, and drug resistance. J. Bioenerg. Biomembr. 29:385–392.
   PubMed Web of Science ®Google Scholar
• Dudley, D. T., L. Pang, S. J. Decker, A. J. Bridges, and A. R. Saltiel. 1995. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA 92:7686–7689.
   PubMed Web of Science ®Google Scholar
• Evan, G., and T. Littlewood. 1998. A matter of life and cell death. Science 281:1317–1322.
   PubMed Web of Science ®Google Scholar
• Goldman, R., and Z. Bar-Shavit. 1979. Dual effect of normal and stimulated macrophages and their conditioned media on target cell proliferation. JNCI 63:1009–1016.
   PubMedGoogle Scholar
• Green, D. R., and J. C. Reed. 1998. Mitochondria and apoptosis. Science 281:1309–1312.
   PubMed Web of Science ®Google Scholar
• Herrlich, P., and F. D. Bohmer. 2000. Redox regulation of signal transduction in mammalian cells. Biochem. Pharmacol. 59:35–41.
   PubMed Web of Science ®Google Scholar
• Honegger, A., T. J. Dull, D. Szapary, A. Komoriya, R. Kris, A. Ullrich, and J. Schlessinger. 1988. Kinetic parameters of the protein tyrosine kinase activity of EGF-receptor mutants with individually altered autophosphorylation sites. EMBO J. 7:3053–3060.
   PubMedGoogle Scholar
• Ip, Y. T., and R. J. Davis. 1998. Signal transduction by the c-Jun N-terminal kinase (JNK)—from inflammation to development. Curr. Opin. Cell Biol. 10:205–219.
   PubMed Web of Science ®Google Scholar
• Irani, K., Y. Xia, J. L. Zweier, S. J. Sollott, C. J. Der, E. R. Fearon, M. Sundaresan, T. Finkel, and P. J. Goldschmidt-Clermont. 1997. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 275:1649–1652.
   PubMed Web of Science ®Google Scholar
• Jacobson, M. D.. 1996. Reactive oxygen species and programmed cell death. Trends Biochem. Sci. 21:83–86.
   PubMed Web of Science ®Google Scholar
• Kamata, H., and H. Hirata. 1999. Redox regulation of cellular signalling. Cell. Signal. 11:1–14.
   PubMed Web of Science ®Google Scholar
• Karin, M.. 1998. Mitogen-activated protein kinase cascades as regulators of stress responses. Ann. N. Y. Acad. Sci. 851:139–146.
   PubMed Web of Science ®Google Scholar
• Kim, R., Y. Ohi, H. Inoue, and T. Toge. 2000. Enhancement of chemotherapeutic agents induced-apoptosis associated with activation of c-Jun N-terminal kinase 1 and caspase 3 (CPP32) in bax-transfected gastric cancer cells. Anticancer Res. 20:439–444.
   PubMedGoogle Scholar
• Kyriakis, J. M., and J. Avruch. 1996. Sounding the alarm: protein kinase cascades activated by stress and inflammation. J. Biol. Chem. 271:24313–24316.
   PubMed Web of Science ®Google Scholar
• Kyriakis, J. M., P. Banerjee, E. Nikolakaki, T. Dai, E. A. Rubie, M. F. Ahmad, J. Avruch, and J. R. Woodgett. 1994. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369:156–160.
   PubMed Web of Science ®Google Scholar
• Lee, J., T. J. Dull, I. Lax, J. Schlessinger, and A. Ullrich. 1989. HER2 cytoplasmic domain generates normal mitogenic and transforming signals in a chimeric receptor. EMBO J. 8:167–173.
   PubMed Web of Science ®Google Scholar
• Levitzki, A., and A. Gazit. 1995. Tyrosine kinase inhibition: an approach to drug development. Science 267:1782–1788.
   PubMed Web of Science ®Google Scholar
• Lewis, T. S., P. S. Shapiro, and N. G. Ahn. 1998. Signal transduction through MAP kinase cascades. Adv. Cancer Res. 74:49–139.
   PubMed Web of Science ®Google Scholar
• Lo, Y. Y. C., J. M. S. Wong, and T. F. Cruz. 1996. Reactive oxygen species mediate cytokine activation of c-Jun NH2-terminal kinases. J. Biol. Chem. 271:15703–15707.
   PubMed Web of Science ®Google Scholar
• Loda, M., P. Capodieci, R. Mishra, H. Yao, C. Corless, W. Grigioni, Y. Wang, C. Magi-Galluzzi, and P. J. Stork. 1996. Expression of mitogen-activated protein kinase phosphatase-1 in the early phases of human epithelial carcinogenesis. Am. J. Pathol. 149:1553–1564.
   PubMed Web of Science ®Google Scholar
• Magi-Galluzzi, C., R. Mishra, M. Fiorentino, R. Montironi, H. Yao, P. Capodieci, K. Wishnow, I. Kaplan, P. J. Stork, and M. Loda. 1997. Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis. Lab. Investig. 76:37–51.
   PubMedGoogle Scholar
• Mendelsohn, J., and Z. Fan. 1997. Epidermal growth factor receptor family and chemosensitization. J. Natl. Cancer Inst. 89:341–343.
   PubMed Web of Science ®Google Scholar
• Minden, A., and M. Karin. 1997. Regulation and function of the JNK subgroup of MAP kinases. Biochim. Biophys. Acta 1333:F85–F104.
   PubMed Web of Science ®Google Scholar
• Miyajima, A., J. Nakashima, K. Yoshioka, M. Tachibana, H. Tazaki, and M. Murai. 1997. Role of reactive oxygen species in cis-dichlorodiammineplatinum-induced cytotoxicity on bladder cancer cells. Br. J. Cancer 76:206–210.
   PubMed Web of Science ®Google Scholar
• Nagane, M., A. Levitzki, A. Gazit, W. K. Cavenee, and H. J. Huang. 1998. Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases. Proc. Natl. Acad. Sci. USA 95:5724–5729.
   PubMed Web of Science ®Google Scholar
• Osherov, N., and A. Levitzki. 1994. Epidermal-growth-factor-dependent activation of the src-family kinases. Eur. J. Biochem. 225:1047–1053.
   PubMedGoogle Scholar
• Pages, G., E. Berra, J. Milanini, A. P. Levy, and J. Pouyssegur. 2000. Stress-activated protein kinases (JNK and p38/HOG) are essential for vascular endothelial growth factor mRNA stability. J. Biol. Chem. 275:26484–26491.
   PubMed Web of Science ®Google Scholar
• Raingeaud, J., S. Gupta, J. S. Rogers, M. Dickens, J. Han, R. J. Ulevitch, and R. J. Davis. 1995. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 270:7420–7426.
   PubMed Web of Science ®Google Scholar
• Reed, J. C.. 1999. Mechanisms of apoptosis avoidance in cancer. Curr. Opin. Oncol. 11:68–75.
   PubMedGoogle Scholar
• Robinson, M. J., and M. H. Cobb. 1997. Mitogen-activated protein kinase pathways. Curr. Opin. Cell Biol. 9:180–186.
   PubMed Web of Science ®Google Scholar
• Tournier, C., P. Hess, D. D. Yang, J. Xu, T. K. Turner, A. Nimnual, D. Bar-Sagi, S. N. Jones, R. A. Flavell, and R. J. Davis. 2000. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288:870–874.
   PubMed Web of Science ®Google Scholar
• Toyokuni, S., K. Okamoto, J. Yodoi, and H. Hiai. 1995. Persistent oxidative stress in cancer. FEBS Lett. 358:1–3.
   PubMed Web of Science ®Google Scholar
• Ushio-Fukai, M., R. W. Alexander, M. Akers, and K. K. Griendling. 1998. p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy. J. Biol. Chem. 273:15022–15029.
   PubMed Web of Science ®Google Scholar
• Verheij, M., R. Bose, X. H. Lin, B. Yao, W. D. Jarvis, S. Grant, M. J. Birrer, E. Szabo, L. I. Zon, J. M. Kyriakis, A. Haimovitz-Friedman, Z. Fuks, and R. N. Kolesnick. 1996. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 380:75–79.
   PubMed Web of Science ®Google Scholar
• Wang, X., J. L. Martindale, Y. Liu, and N. J. Holbrook. 1998. The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival. Biochem. J. 333:291–300.
   PubMed Web of Science ®Google Scholar
• Wilhelm, D., K. Bender, A. Knebel, and P. Angel. 1997. The level of intracellular glutathione is a key regulator for the induction of stress-activated signal transduction pathways including Jun N-terminal protein kinases and p38 kinase by alkylating agents. Mol. Cell. Biol. 17:4792–4800.
   PubMed Web of Science ®Google Scholar
• Wong, T. W., H. Y. Yu, S. K. Kong, K. P. Fung, and T. T. Kwok. 2000. The decrease of mitochondrial NADH dehydrogenase and drug induced apoptosis in doxorubicin resistant A431 cells. Life Sci. 67:1111–1118.
   PubMedGoogle Scholar
• Xia, Z., M. Dickens, J. Raingeaud, R. J. Davis, and M. E. Greenberg. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326–1331.
   PubMed Web of Science ®Google Scholar
• Zindy, F., C. M. Eischen, D. H. Randle, T. Kamijo, J. L. Cleveland, C. J. Sherr, and M. F. Roussel. 1998. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12:2424–2433.
   PubMed Web of Science ®Google Scholar
• Zor, T., and Z. Selinger. 1996. Linearization of the Bradford protein assay increases its sensitivity: theoretical and experimental studies. Anal. Biochem. 236:302–308.
   PubMed Web of Science ®Google Scholar